COYO-GMBH
20.7.2021 16:28:52 CEST | Business Wire | Press release
COYO, the leading social intranet and employee communications platform, lands a coup with the acquisition of Paris-based people analytics platform Jubiwee. For the past 5 years Jubiwee has been doubling its operations and customer-base yearly. Over 40 French blue-chip companies use Jubiwee to assess staff motivation or to support transformation projects. In joining forces with Jubiwee, COYO accelerates its internationalization outside the DACH region and adds a critical toolkit to its digital workplace proposition.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005881/en/
Since the virus fast-tracked remote work, countless businesses have learned that their operational effectiveness in remote scenarios was heavily dependent on employee engagement. With Jubiwee's engagement analytics tools and their own communications and intranet platform, COYO now brings a complete employee engagement offering to the market. Customers will be enabled to address the limitations of remote work and make it more successful for employers and employees alike.
To ensure continuity and stability both company- and product-wise, Thibaud Martin, co-founder of Jubiwee, will join the COYO management team. Jubiwee’s office in Paris will become COYO’s French head office. Jubiwee customers have already been informed that their product of choice will be continued and even enhanced.
With the ambition to build ‘sexy and engaging business software’, Hamburg-based tech entrepreneur Jan Marius Marquardt founded COYO in 2010. The current platform is a modern social intranet and employee app that empowers organizations to drive employee engagement and improve workplace culture. The platform has over 400 customers, serving more than 1 million end-users. Jan Marius Marquardt, founder and CEO of COYO, says: “I am beyond happy about joining forces with Jubiwee: It feels like the right step, pushing the company and product to the next level and accelerate our expansion to France, one of our priority markets. Beyond cool technology there is no better way to start building up a French presence than by teaming up with a French team that has already proven successful and shares our values. This addition is a next big step towards becoming the most widely adopted employee communications platform in the world.”
Both companies have European DNA, share the same culture and vision and are very product-focused: UX and UI are critical, while user adoption is above-market. Jubiwee’s tech and UX-centered product resonates strongly with COYO’s product philosophy. Jan Marius Marquardt explains: “A capable engagement analytics solution is instrumental in a truly 360° employee communications offering and will bring a lot of value to customers. The merger thus presents an excellent opportunity for both current German and French customers.”
Jubiwee was founded in 2016 by Thibaud Martin, Victor Mustar, and Antoine Bellion. The company offers a new generation engagement analytics platform with a user-centric approach to improve employee experience, reduce turnover and improve retention. Thibaud Martin, co-founder, and CEO of Jubiwee, explains: “The people analytics and overall employee engagement market has grown tremendously in recent months, partly due to the COVID-crisis. Also, customers have grown more mature and demanding. To capitalize on this shift, we decided to partner with a strong, renowned, and ambitious company that shares the same values: COYO. Joining forces with COYO is the best way to build a more comprehensive offer and accelerate at this crucial time.”
Both solutions will be continued in their current form and developed according to their respective roadmaps. Short-term ambitions include continuing Jubiwee’s growth in France, cross-selling respective solutions to existing customers and prospects as well as introducing the COYO offer in France. Mid and long-term ambitions include integrating both solutions to offer a complete employee engagement suite, enabling companies to communicate, and take the pulse of their coworkers in a modern, efficient and seamless way. Overall, the companies’ solutions are complementary and together present a strong offering, both in terms of depth and breadth. By adding two very competent best-of-breed solutions, COYO and Jubiwee are creating one extremely compelling suite.
More information is available at www.coyoapp.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210720005881/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
